
Cerevel Therapeutics Holdings, Inc. CERE
Trading inactive
CERE
Cerevel Therapeutics Holdings, Inc. ROIV
Roivant Sciences Ltd. BPMC
Blueprint Medicines Corporation IMGN
ImmunoGen, Inc. RXDX
Prometheus Biosciences, Inc. ISEE
IVERIC bio, Inc. RETA
Reata Pharmaceuticals, Inc. OSH
Oak Street Health, Inc. SWTX
SpringWorks Therapeutics, Inc. MRTX
Mirati Therapeutics, Inc.
Cerevel Therapeutics Holdings, Inc. ROIV
Roivant Sciences Ltd. BPMC
Blueprint Medicines Corporation IMGN
ImmunoGen, Inc. RXDX
Prometheus Biosciences, Inc. ISEE
IVERIC bio, Inc. RETA
Reata Pharmaceuticals, Inc. OSH
Oak Street Health, Inc. SWTX
SpringWorks Therapeutics, Inc. MRTX
Mirati Therapeutics, Inc.
Performance
Periode | CERE | ROIV | BPMC | IMGN | RXDX | ISEE | RETA | OSH | SWTX | MRTX |
---|---|---|---|---|---|---|---|---|---|---|
6M | 9.66 % | 77.99 % | 39.99 % | 98.95 % | 64.88 % | 88.98 % | 72.79 % | 80.39 % | 25.31 % | 55.04 % |
YTD | 6.52 % | 47.93 % | 48.46 % | 5.31 % | 87.54 % | 98.56 % | 369.52 % | 83.27 % | 30.24 % | -0.69 % |
1Y | 87.88 % | 53.79 % | 35.28 % | 726.32 % | 576.55 % | 198.58 % | 424.85 % | 106.57 % | 30.85 % | 29.44 % |
3Y | 45.17 % | 302.48 % | 111.64 % | 250.96 % | 690.51 % | 781.90 % | 50.36 % | -2.50 % | 67.46 % | -70.69 % |
5Y | 277.82 % | 71.83 % | 71.29 % | 1 083.14 % | 690.51 % | 1 504.42 % | 196.35 % | -2.50 % | 10.23 % | -22.29 % |
10Y | 277.82 % | 71.83 % | 335.16 % | 93.17 % | 690.51 % | 51.90 % | 1 218.75 % | -2.50 % | 107.64 % | 171.51 % |
From the beginning | 277.82 % | 71.83 % | 586.06 % | 228.79 % | 690.51 % | 51.90 % | 1 218.75 % | -2.50 % | 107.64 % | 732.62 % |